Tumor-associated macrophages in metastasizing tumors.

[1]  A. Mantovani,et al.  Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice. , 1987, Journal of immunology.

[2]  A. Mantovani,et al.  Expression of c-fos protooncogene in normal human peripheral blood granulocytes , 1987, The Journal of experimental medicine.

[3]  D. Radzioch,et al.  Augmentation of c-fos mRNA expression by activators of protein kinase C in fresh, terminally differentiated resting macrophages , 1987, Molecular and cellular biology.

[4]  A. Mantovani,et al.  Ia antigen expression and IL-1 activity in murine tumour-associated macrophages. , 1986, Immunology.

[5]  A. Mantovani,et al.  Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants. , 1986, Journal of immunology.

[6]  A. Mantovani,et al.  Induction of monocyte-macrophage procoagulant activity by transformed cell lines. , 1986, Journal of immunology.

[7]  A. Mantovani,et al.  The Macrophage Content of Tumors Is Unrelated to Levels of NK Cell‐Mediated Resistance , 1986, Journal of leukocyte biology.

[8]  A. Mantovani,et al.  Tumor‐derived chemotactic factor(S) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues , 1985, International journal of cancer.

[9]  A. Mantovani,et al.  Prostacyclin synthesis induced in vascular cells by interleukin-1. , 1985, Science.

[10]  G. Nicolson,et al.  Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages. , 1985, Cancer research.

[11]  G. Poste,et al.  Changes in the macrophage content of lung metastases at different stages in tumor growth. , 1985, The American journal of pathology.

[12]  P. De Baetselier,et al.  Selecting, accelerating and suppressing interactions between macrophages and tumor cells. , 1985, Invasion & metastasis.

[13]  P. Polverini,et al.  Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[14]  A. J. Valente,et al.  Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. , 1984, The American journal of pathology.

[15]  G. Heppner,et al.  Mutagenic activity of tumor-associated macrophages in Salmonella typhimurium strains TA98 and TA 100. , 1984, Cancer research.

[16]  A. Mantovani,et al.  Procoagulant activity of macrophages associated with different murine neoplasms , 1984, International journal of cancer.

[17]  R. Cullen,et al.  In Situ Proliferation of Intratumor Macrophages , 1984, Journal of leukocyte biology.

[18]  P. Allavena,et al.  Human large granular lymphocytes are potent producers of interleukin-1 , 1984, Nature.

[19]  A. Mantovani,et al.  Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. , 1984, Journal of immunology.

[20]  S. Alberti,et al.  Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors , 1984, International journal of cancer.

[21]  J. Estes,et al.  Macrophage‐Derived Growth Factor for Fibroblasts and Interleukin‐1 Are Distinct Entities , 1984, Journal of leukocyte biology.

[22]  J. Djeu,et al.  Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. , 1983, Journal of immunology.

[23]  G. Heppner,et al.  Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors. , 1983, Journal of immunology.

[24]  C. Stewart.  Local proliferation of mononuclear phagocytes in tumors. , 1983, Journal of the Reticuloendothelial Society.

[25]  G. Nicolson,et al.  Differences in the sensitivities of murine metastatic lymphoma/lymphosarcoma variants to macrophage-mediated cytolysis and/or cytostasis. , 1983, Cancer research.

[26]  H. Schreiber,et al.  Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity , 1983, The Journal of experimental medicine.

[27]  A. Mantovani,et al.  Chemotactic activity for mononuclear phagocytes of culture supernatants from murine and human tumor cells: Evidence for a role in the regulation of the macrophage content of neoplastic tissues , 1983, International journal of cancer.

[28]  S. Haskill,et al.  Activities of macrophages within and peripheral to the tumor mass. , 1983 .

[29]  J. Lewis,et al.  In vitro growth stimulation of human ovarian cancer cells by xenogeneic peritoneal macrophages. , 1982, Journal of the National Cancer Institute.

[30]  S. Haskill,et al.  Mononuclear-cell infiltration in ovarian cancer. III. Suppressor-cell and ADCC activity of macrophages from ascitic and solid ovarian tumours. , 1982, British Journal of Cancer.

[31]  R. Lane,et al.  Characterization of a macrophage chemokinetic factor in tumor cell culture media. , 1982, Journal of the Reticuloendothelial Society.

[32]  R. Evans,et al.  Macrophage accumulation in transplanted tumors is not dependent on host immune responsiveness or presence of tumor-associated rejection antigens. , 1981, Journal of the Reticuloendothelial Society.

[33]  J. Ortaldo,et al.  Natural killer cells: their roles in defenses against disease. , 1981, Science.

[34]  R. Snyderman,et al.  Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses. , 1981, The Journal of clinical investigation.

[35]  A. Mantovani,et al.  Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: Augmentation by interferon, lymphokines and endotoxin , 1981, International journal of cancer.

[36]  D. Nelson,et al.  I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages. , 1981, The American journal of pathology.

[37]  I. Fidler,et al.  Macrophage content of metastatic and nonmetastatic rodent neoplasms. , 1981, Journal of immunology.

[38]  A. Mantovani,et al.  In vitro effects on tumor cells of macrophages isolated from an early‐passage chemically‐induced murine sarcoma and from its spontaneous metastases , 1981, International journal of cancer.

[39]  A. Mantovani,et al.  Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors. , 1980, Journal of the National Cancer Institute.

[40]  A. Mantovani,et al.  Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice , 1980, International journal of cancer.

[41]  S. Salmon,et al.  Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions. , 1980, British Journal of Cancer.

[42]  C. Nathan,et al.  The Release of Hydrogen Peroxide from Mononuclear Phagocytes and its Role in Extracellular Cytolysis , 1980 .

[43]  R. Snyderman,et al.  Do macrophages destroy nascent tumors? , 1979, Journal of the National Cancer Institute.

[44]  A. Mantovani,et al.  Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors , 1979, International journal of cancer.

[45]  A. Mantovani,et al.  Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity , 1978, International journal of cancer.

[46]  R. Evans,et al.  Macrophage requirement for growth of a murine fibrosarcoma. , 1978, British Journal of Cancer.

[47]  E. Unanue,et al.  Activated macrophages induce vascular proliferation , 1977, Nature.

[48]  K. Moore,et al.  Intra‐tumour host cells of transplanted rat neoplasms of different immunogenicity , 1977, International journal of cancer.

[49]  M. Meltzer,et al.  Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors. , 1977, Cancer research.

[50]  M. Meltzer,et al.  Depressed chemotactic responses in vitro of peritoneal macrophages from tumor-bearing mice. , 1976, Journal of the National Cancer Institute.

[51]  S. Eccles,et al.  Macrophage content of tumours in relation to metastatic spread and host immune reaction , 1974, Nature.

[52]  E. Leonard,et al.  Abnormal monocyte chemotactic response in cancer patients. , 1974, Journal of the National Cancer Institute.

[53]  P. Sherlock,et al.  Adrenal steroids and the pattern of metastases of breast cancer. , 1962, JAMA.